针对性FOX家庭治疗在卵巢癌中的进展
Hairong Zhang1, Cuiping Gong1, Xin Lv1
1Department of Obstetrics and Gynecology, Shandong Provincial Third Hospital, Shandong University, Ji'nan, China.
Frontiers in pharmacology
|August 1, 2025
概括
卵巢癌 (OC) 是一种致命的疾病,通常是晚诊断的. 本综述探讨了分叉盒 (FOX) 蛋白质如何影响OC进展,并讨论了新的FOX向疗法,以获得更好的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 卵巢癌 (OC) 是女性癌症死亡的主要原因,原因是晚期检测和治疗阻力.
- 目前的手术和化疗等疗法对OC复发和转移的疗效有限.
- 由于OC的异质性,需要确定新的治疗点.
研究的目的:
- 审查分叉盒 (FOX) 蛋白在卵巢癌发病和进展中的作用.
- 总结一下FOX向性治疗策略的最新进展.
主要方法:
- 对卵巢癌中FOX家族成员研究的文献综述.
- 对OC细胞行为中的FOX蛋白失调的分析.
- 检查新兴的FOX向治疗方法.
主要成果:
- 对FOX蛋白质的失调有助于OC的扩散,亡抵抗,入侵和耐药性.
- 特定的FOX蛋白在OC发育中具有上下文依赖的作用.
- 针对FOX家族成员的向显示了新的OC治疗策略的前景.
结论:
- 狐蛋白是OC病原和进展的关键调节者.
- 准FOX家族成员是开发更有效的卵巢癌疗法的一个有希望的途径.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K


